IDEXX Laboratories, Inc. provided financial guidance for 2024. For the period, The company expects revenue of $3,930 million - $4,040 million. EPS $10.84 - $11.33.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
499.3 USD | +2.06% | +4.82% | -10.04% |
Apr. 01 | Elanco Animal Health Appoints Two Ancora Holdings' Nominees to Board | MT |
Apr. 01 | Elanco appoints two directors after settling with activist Ancora | RE |
EPS Revisions
- Stock Market
- Equities
- IDXX Stock
- News IDEXX Laboratories, Inc.
- IDEXX Laboratories, Inc. Provides Financial Guidance for 2024